Predictors of Prognosis in Light-Chain Amyloidosis and Chronological Changes in Cardiac Morphology and Function

Masashi Amano1, Chisato Izumi1, Shunsuke Nishimura1

  • 1Department of Cardiology, Tenri Hospital, Tenri, Japan.

Insights

Prognosis for cardiac AL amyloidosis remains poor, with diastolic wall strain (DWS) identified as a key predictor of death. Worsening DWS and cardiac changes indicate a grim outlook for affected patients.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Amyloidosis Research

Background:

  • Cardiac AL amyloidosis presents a significant mortality risk despite advancements in treatment.
  • Limited data exists on prognostic indicators and temporal changes in cardiac structure and function.

Purpose of the Study:

  • To evaluate prognosis and identify predictors of mortality in cardiac AL amyloidosis.
  • To assess longitudinal changes in cardiac morphology and function.

Main Methods:

  • Retrospective analysis of 36 consecutive patients with cardiac AL amyloidosis.
  • Evaluation of prognostic factors including left ventricular wall thickness and diastolic wall strain (DWS).
  • Assessment of chronological changes in cardiac dimensions and function over the follow-up period.

Main Results:

  • The median survival time was 0.85 years; 3-year death-free rates were 26% (all-cause) and 36% (cardiac).
  • Female sex and higher DWS were independent predictors of all-cause mortality.
  • A DWS cutoff of 0.189 predicted 1-year all-cause death with 78% sensitivity and 72% specificity (AUC=0.726).
  • Patients who died within 1 year showed decreased left ventricular size and stroke volume, and worsening DWS compared to survivors.
  • Progressive diastolic dysfunction and left ventricular cavity narrowing were observed in patients with poor prognosis.

Conclusions:

  • Cardiac AL amyloidosis carries a poor prognosis.
  • Diastolic wall strain (DWS) is a significant predictor of outcomes in cardiac AL amyloidosis.
  • Short-term follow-up reveals detrimental cardiac remodeling and functional decline in non-survivors.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
550
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
634
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
628
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
506